{
    "organizations": [],
    "uuid": "0abddbdced59673d6a08ba8056da289815cbbb66",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-adocia-starts-first-in-human-clini/brief-adocia-starts-first-in-human-clinical-study-of-biochaperone-pramlintide-insulin-idUSASO0003AN",
    "ord_in_thread": 0,
    "title": "BRIEF-Adocia Starts First-In-Human Clinical Study Of BioChaperone Pramlintide Insulin",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - ADOCIA SA:\n* ADOCIA INITIATES FIRST-IN-HUMAN CLINICAL STUDY OF BIOCHAPERONEÂ® PRAMLINTIDE INSULIN IN PEOPLE WITH TYPE 1 DIABETES\n* STUDY IS EXPECTED TO BE COMPLETED IN Q3 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-16T13:52:00.000+03:00",
    "crawled": "2018-04-17T12:31:05.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "adocia",
        "sa",
        "adocia",
        "initiate",
        "clinical",
        "study",
        "pramlintide",
        "insulin",
        "people",
        "type",
        "diabetes",
        "study",
        "expected",
        "completed",
        "q3",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}